Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.85 USD | +5.43% | -5.12% | +2.34% |
05-07 | Transcript : SOPHiA GENETICS SA, Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | SOPHiA GENETICS SA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.34% | 300M | |
+9.63% | 3,051B | |
+6.65% | 83.97B | |
+4.84% | 76.9B | |
-13.91% | 54B | |
+23.53% | 48.01B | |
-24.41% | 46.47B | |
+22.65% | 42.04B | |
+62.94% | 38.34B | |
-33.17% | 24.97B |
- Stock Market
- Equities
- SOPH Stock
- News SOPHiA GENETICS SA
- Sophia Genetics, AstraZeneca Expand Project to Improve Access to Ovarian Cancer Testing in Spain